SCHEMBL20095

SCHEMBL20095

O=C(O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.69
MAPT P10636 3/20 0.69
HPGD P15428 2/20 0.69
MEN1 O00255 2/20 0.69
HTT P42858 2/20 0.69
KMT2A Q03164 2/20 0.69
CYP2C19 P33261 1/20 0.69
RECQL P46063 1/20 0.69
BLM P54132 1/20 0.69
SMAD3 P84022 1/20 0.69
PRMT1 Q99873 1/20 0.69
ACE2 Q9BYF1 1/20 0.69
TDP1 Q9NUW8 1/20 0.69
ALOX12 P18054 2/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP2C9 P11712 1/20 0.52
ALOX15 P16050 1/20 0.52
BRCA1 P38398 1/20 0.52
HSD17B10 Q99714 1/20 0.52
LMNA P02545 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29838678 1.00 FTO (0.69) FTOMAPTHPGDMEN1HTT
SCHEMBL29996062 1.00 FTO (0.69) FTOMAPTHPGDMEN1HTT
SCHEMBL29358729 1.00 FTO (0.69) FTOMAPTHPGDMEN1HTT
SCHEMBL23158785 0.99 FTO (0.67) FTOMAPTHPGDMEN1HTT
SCHEMBL28092031 0.99 FTO (0.67) FTOMAPTHPGDMEN1HTT
SCHEMBL27475520 0.99 FTO (0.67) FTOMAPTHPGDMEN1HTT
Water SCHEMBL25247555 0.99 FTO (0.67) FTOMAPTHPGDMEN1HTT
Ammonia Solution, Strong SCHEMBL29083296 0.99 FTO (0.67) FTOMAPTHPGDMEN1HTT
Water SCHEMBL29653557 0.99 FTO (0.67) FTOMAPTHPGDMEN1HTT
Oxalic Acid SCHEMBL27598167 0.97 FTO (0.66) FTOMAPTHPGDMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 17687 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070479-A Ultrasonic indicating device and method for monitoring ultrasonic treatment JP实验室股份有限公司 2026-05-19 CN claimed
US-20260132218-A1 FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN HER-2 A & G PHARMACEUTICAL INC (US) 2026-05-14 US claimed
US-12600699-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-14 US claimed
EP-4695300-A2 ANTIBODIES AND CONJUGATES AGAINST PROSTAGLANDIN F2 RECEPTOR INHIBITOR AND USES THEREOF A & G Pharmaceutical, Inc. (US) 2026-02-18 EP claimed
EP-4409261-B1 METHOD FOR DETECTING, QUANTIFYING AND CHARACTERISING BRETTANOMYCES SPP. AND OTHER YEASTS CONTAINED IN AN ORGANIC LIQUID SUBSTRATE CONTAINING FERMENTABLE SUGARS MD INVENT OENO (FR) 2026-02-11 EP claimed
US-12533425-B2 Methods and systems using peptides for targeting and mapping human nerves in image guided surgery, diagnostics and therapeutic delivery ALUME BIOSCIENCES, INC. (US) 2026-01-27 US claimed
US-12492422-B2 Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment Sunbird Bio, Inc. (US) 2025-12-09 US claimed
US-20250340957-A1 Assays for the Detection of SARS-CoV2 Mutants PROCOMCURE BIOTECH GMBH (AT) 2025-11-06 US claimed
EP-4394016-B1 CHEMILUMINESCENT SUBSTRATE SOLUTION, CHEMILUMINESCENCE ENHANCER AND USE THEREOF SHENZHEN MINDRAY BIOMEDICAL ELECTRONICS CO LTD (CN) 2025-08-20 EP claimed
EP-4313156-B1 DISULFIDE-BASED PRODRUG COMPOUNDS UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2025-08-06 EP claimed
US-5340750-A Reagents and methods for the quantification of imipramine or desipramine in biological fluids ABBOTT LABORATORIES (US) 1994-08-23 US claimed
US-5332661-A Reagents and methods for the quantification of total doxepins in biological fluids ABBOTT LABORATORIES (US) 1994-07-26 US claimed
EP-0599935-A1 REAGENTS AND METHODS FOR THE QUANTIFICATION OF AMITRIPTYLINE OR NORTRIPTYLINE IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1994-06-08 EP claimed
WO-1993020442-A1 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES ABBOTT LABORATORIES (US) 1993-10-14 WO claimed
WO-1993003372-A1 REAGENTS AND METHODS FOR THE QUANTIFICATION OF TOTAL DOXEPINS IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1993-02-18 WO claimed
WO-1993003371-A1 REAGENTS AND METHODS FOR THE QUANTIFICATION OF IMIPRAMINE OR DESIPRAMINE IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1993-02-18 WO claimed
WO-1993003370-A1 REAGENTS AND METHODS FOR THE QUANTIFICATION OF AMITRIPTYLINE OR NORTRIPTYLINE IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1993-02-18 WO claimed
US-5145790-A Immunoassay, fluorescein derivative ABBOTT LABORATORIES (US) 1992-09-08 US claimed
EP-0184630-A3 FLUORESCENCE POLARIZATION ASSAY, REAGENTS, AND METHOD OF MAKING REAGENTS, FOR DETERMINATION OF DIGITOXIN ABBOTT LABORATORIES (US) 1986-08-27 EP claimed
EP-0184630-A2 Fluorescence polarization assay, reagents, and method of making reagents, for determination of digitoxin ABBOTT LABORATORIES (US) 1986-06-18 EP claimed